Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors

SIMPLE SUMMARY: There is an unmet need for new predictive biomarkers associated with efficacy and immune-related toxicity of immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC). In this study, we performed multiplex ELISA screening in plasma from 35 consecutive patients with ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantini, Adrien, Takam Kamga, Paul, Julie, Catherine, Corjon, Alexandre, Dumenil, Coraline, Dumoulin, Jennifer, Ouaknine, Julia, Giraud, Violaine, Chinet, Thierry, Rottman, Martin, Emile, Jean-François, Giroux Leprieur, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795942/
https://www.ncbi.nlm.nih.gov/pubmed/33396187
http://dx.doi.org/10.3390/cancers13010097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795942/
https://www.ncbi.nlm.nih.gov/pubmed/33396187
http://dx.doi.org/10.3390/cancers13010097

Ejemplares similares